Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study.
about
Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig modelIs there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).
P2860
Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II trial of 5-fluorourac ...... apeutics research group study.
@ast
Phase II trial of 5-fluorourac ...... apeutics research group study.
@en
type
label
Phase II trial of 5-fluorourac ...... apeutics research group study.
@ast
Phase II trial of 5-fluorourac ...... apeutics research group study.
@en
prefLabel
Phase II trial of 5-fluorourac ...... apeutics research group study.
@ast
Phase II trial of 5-fluorourac ...... apeutics research group study.
@en
P2093
P356
P1476
Phase II trial of 5-fluorourac ...... apeutics research group study.
@en
P2093
Alex Y Chang
Foo Kian Fong
Gilberto Lopes
Koo Wen Hsin
Robert Lim
P304
P356
10.3816/CCC.2007.N.033
P407
P577
2007-09-01T00:00:00Z